5F4N
Multi-parameter lead optimization to give an oral CHK1 inhibitor clinical candidate: (R)-5-((4-((morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile (CCT245737)
History
Please read more about PDB versioning on our help page.
| Version | Date | Type | |
| 1-0 | 2016-05-25 | Initial release | No files available. |
| 1-1 | 2016-06-22 | Database references | No files available. |
| 1-2 | 2024-05-08 | Data collection, Database references |
